Clinical Trial Update: Co-transplantation of MSC in the Setting of Allo-HSCT [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update for co-transplantation of mesenchymal stem cells (MSC) in the setting of allogeneic hematopoietic stem cell transplantation across Phase 2…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allogeneic Hematopoietic Stem Cell Transplantation-related Conditions

Snippet

Sponsor: Fujian Medical University | Conditions: Allogeneic Hematopoietic Stem Cell Transplantation | Phase 2, Phase 3 | Status: UNKNOWN